HomeCompareEMNSF vs ORCC

EMNSF vs ORCC: Dividend Comparison 2026

EMNSF yields 2.04% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMNSF wins by $1.2K in total portfolio value· pulled ahead in Year 6
10 years
EMNSF
EMNSF
● Live price
2.04%
Share price
$1.96
Annual div
$0.04
5Y div CAGR
-0.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.6K
Annual income
$223.19
Full EMNSF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — EMNSF vs ORCC

📍 EMNSF pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMNSFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMNSF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMNSF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMNSF
Annual income on $10K today (after 15% tax)
$173.47/yr
After 10yr DRIP, annual income (after tax)
$189.71/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, EMNSF beats the other by $188.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMNSF + ORCC for your $10,000?

EMNSF: 50%ORCC: 50%
100% ORCC50/50100% EMNSF
Portfolio after 10yr
$22.0K
Annual income
$112.12/yr
Blended yield
0.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

EMNSF
Analyst Ratings
3
Buy
Consensus: Buy
Altman Z
3.4
Piotroski
6/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMNSF buys
0
ORCC buys
0
No recent congressional trades found for EMNSF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMNSFORCC
Forward yield2.04%9.79%
Annual dividend / share$0.04$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-0.4%-50%
Portfolio after 10y$22.6K$21.4K
Annual income after 10y$223.19$1.04
Total dividends collected$2.1K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: EMNSF vs ORCC ($10,000, DRIP)

YearEMNSF PortfolioEMNSF Income/yrORCC PortfolioORCC Income/yrGap
1$10,903$203.27$11,190$489.61$287.00ORCC
2$11,873$206.30$12,229$256.01$356.00ORCC
3$12,913$209.11$13,216$130.74$303.00ORCC
4$14,029$211.70$14,207$66.02$178.00ORCC
5$15,225$214.08$15,234$33.17$9.00ORCC
6← crossover$16,507$216.27$16,317$16.62+$190.00EMNSF
7$17,880$218.26$17,468$8.32+$412.00EMNSF
8$19,352$220.07$18,695$4.16+$657.00EMNSF
9$20,928$221.72$20,006$2.08+$922.00EMNSF
10$22,617$223.19$21,407$1.04+$1.2KEMNSF

EMNSF vs ORCC: Complete Analysis 2026

EMNSFStock

Elementis plc operates as a specialty chemical company in the United Kingdom, North America, rest of Europe, and internationally. It operates through four segments: Personal Care, Coatings, Talc, and Chromium. The Personal Care segment produces and sells rheological modifiers and compounded products for antiperspirants/deodorants, bath and soap, color cosmetics, and hair and skin care products. The Coatings segment produces and sells rheological modifiers and additives for industrial finishes, architectural coatings, construction, adhesives and sealants, inks, colorant dispersions, and specialty applications; and bentonite and hectorite clays, as well as polymer-based additives used in drilling, simulation, and cementing applications. The Talc segment produces and supplies talc for use in plastics, paints and coatings, food and pharmaceuticals, ceramics, polyester putties, paper, and pulp sectors. The Chromium segment produces chromium chemicals, such as chromic oxide, chromic acid, chrome sulfate, sodium dichromate, and sodium sulfate for use in pigments, cosmetics, refractories, chrome metal production, metal and plastic finishing, wood treatment, leather tanning, trivalent metal finishing, coatings, and metal passivation, as well as for making detergents, glasses, papers, and starches. It also offers personal care products, waxes, additives and resins, organoclays, colourants, and other specialty additives. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.

Full EMNSF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this EMNSF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMNSF vs SCHDEMNSF vs JEPIEMNSF vs OEMNSF vs KOEMNSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.